×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Michael Zinda

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
RPTXRepare Therapeutics Inc.Michael ZindaEVP, CHIEF SCIENTIFIC OFFICERMar 12, 2025Sale$1.145,6116,39780,297Mar 14, 2025, 04:30 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, CHIEF SCIENTIFIC OFFICERMar 28, 2024Sale$4.644502,08872,318Apr 01, 2024, 09:28 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, CHIEF SCIENTIFIC OFFICERApr 01, 2024Sale$4.664101,91171,908Apr 01, 2024, 09:28 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, CHIEF SCIENTIFIC OFFICERMar 25, 2024Sale$4.784502,15173,668Mar 27, 2024, 06:57 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, CHIEF SCIENTIFIC OFFICERMar 26, 2024Sale$4.614502,07573,218Mar 27, 2024, 06:57 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, CHIEF SCIENTIFIC OFFICERMar 27, 2024Sale$4.624502,07972,768Mar 27, 2024, 06:57 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, Chief Scientific OfficerJun 07, 2023Sale$12.036,40477,04062,987Jun 09, 2023, 04:25 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, Chief Scientific OfficerJun 08, 2023Sale$12.022,86934,48560,118Jun 09, 2023, 04:25 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, Chief Scientific OfficerJun 06, 2023Sale$12.041,20014,44869,391Jun 07, 2023, 04:55 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, Chief Science OfficerMar 15, 2022Sale$11.305336,02346,041Mar 16, 2022, 04:04 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, Chief Science OfficerNov 23, 2021Option/RSU Exercise$2.0046,04191,94846,574Dec 06, 2021, 04:47 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, Chief Science OfficerNov 15, 2021Sale$27.3320,000546,6134,433Nov 17, 2021, 07:46 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, Chief Science OfficerAug 16, 2021Sale$33.9915,000509,88621,233Aug 20, 2021, 04:24 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, Chief Science OfficerDec 29, 2020Sale$33.6719,696663,09755,690Dec 30, 2020, 05:10 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, Chief Science OfficerDec 28, 2020Option/RSU Exercise$2.06489985,277Dec 30, 2020, 05:10 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, Chief Science OfficerDec 28, 2020Sale$34.2515,048515,35970,551Dec 30, 2020, 05:10 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, Chief Science OfficerDec 23, 2020Sale$33.6616,235546,41788,908Dec 28, 2020, 04:40 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, Chief Science OfficerDec 24, 2020Option/RSU Exercise$2.0643289185,661Dec 28, 2020, 04:40 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, Chief Science OfficerDec 24, 2020Sale$33.1443214,31685,229Dec 28, 2020, 04:40 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, Chief Science OfficerDec 22, 2020Option/RSU Exercise$1.9041,31278,510126,541Dec 28, 2020, 04:40 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, Chief Science OfficerDec 22, 2020Sale$33.3841,3121,379,200124,929Dec 28, 2020, 04:40 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, Chief Science OfficerDec 23, 2020Option/RSU Exercise$2.2216,23536,081101,464Dec 28, 2020, 04:40 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, Chief Science OfficerDec 21, 2020Option/RSU Exercise$2.4240,00097,000125,229Dec 22, 2020, 04:37 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, Chief Science OfficerDec 21, 2020Sale$33.0840,0001,323,20085,229Dec 22, 2020, 04:37 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, Chief Science OfficerDec 16, 2020Option/RSU Exercise$1.648,95614,66194,185Dec 18, 2020, 08:29 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, Chief Science OfficerDec 16, 2020Sale$35.268,956315,76786,163Dec 18, 2020, 08:29 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, Chief Science OfficerDec 18, 2020Option/RSU Exercise$2.068,32117,15893,550Dec 18, 2020, 08:29 PM
RPTXRepare Therapeutics Inc.Michael ZindaEVP, Chief Science OfficerDec 18, 2020Sale$34.608,321287,92585,429Dec 18, 2020, 08:29 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe